Study Sheds Light on Real Life Science Returns

So how do milestone payments usually work out in life science acquisitions? A new report on the subject finds that sometimes investors get a lot of money, but other times they don’t make anything. And in many cases, the best answer may simply be: It’s complicated.

ManagersNorth AmericaUSBriefs